CLASS II ONGOING Device recall · Reported 5 Jul 2023 · FDA Enforcement Report

Legacy Smartbase, Ne 3.0d 1mml recalled by Implant Direct Sybron

Implant Direct Sybron Manufacturing is recalling Legacy Smartbase, Ne 3.0d 1mml, distributed nationwide in the US. The recall was initiated on 2 May 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF/UDI-DI/Lot: 8730-81NE/10841307123002/92637, 131309; 8730-82NE/10841307123019/92638, 163063; 8735-80NNE/10841307123026/160542; 8735-82NE/10841307123064/15002360; 8745-80NNE/10841307123033/15004780; 8745-82NE/10841307123071/182029;
Quantity recalled29

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2037-2023
FDA event ID
92415
Recalling firm
Implant Direct Sybron Manufacturing, Westlake Village, CA
Classification
Class II
Status
Ongoing
Recall initiated
2 May 2023
FDA classified
29 Jun 2023
Reported
5 Jul 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

2 May 2023Recall initiated by company
29 Jun 2023Classified by FDA+58 days
5 Jul 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Non-engaging abutments were distributed without FDA clearance; the performance characteristics have not yet been adequately established.

Product as listed by the FDA

LEGACY SMARTBASE, NE 3.0D 1MML, REF: 8730-81NE; LEGACY SMARTBASE, NE 3.0D 2MML, REF 8730-82NE; LEGACY SMARTBASE NARROW NE 3.5D, REF: 8735-80NNE; LEGACY SMARTBASE, NE 3.5D 2MML, REF: 8735-82NE LEGACY SMARTBASE NARROW NE 4.5D, REF: 8745-80NNE; LEGACY SMARTBASE. NE 4.5D, REF: 8745-82NE;

Where it was distributed

US Nationwide distribution in the states of FL, ID, TX, CA.

Nationwide CaliforniaFloridaIdahoTexas

Questions about this recall

Why was it recalled?

Non-engaging abutments were distributed without FDA clearance; the performance characteristics have not yet been adequately established.

Which lots are affected?

REF/UDI-DI/Lot: 8730-81NE/10841307123002/92637, 131309; 8730-82NE/10841307123019/92638, 163063; 8735-80NNE/10841307123026/160542; 8735-82NE/10841307123064/15002360; 8745-80NNE/10841307123033/15004780; 8745-82NE/10841307123071/182029;

Where was it sold?

US Nationwide distribution in the states of FL, ID, TX, CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Implant Direct Sybron Manufacturing

All 33

Other Other Medical Devices recalls

All 13,778